Company intelligence / Profile preview

1077801 B.C. Ltd.

Burnaby, British Columbia, Canada

Ownership: Private
Development stage: Other

Overview

1077801 B.C. Ltd. is a Canadian holding company established as a special purpose acquisition vehicle to take Response Biomedical Corp. private in 2016. It acquired Response Biomedical for $1.12 CAD per share, making Response its wholly-owned subsidiary. Response Biomedical specializes in rapid immunoassay diagnostic tests using its RAMP platform for various applications, including cardiac, infectious diseases, and biodefense. 1077801 B.C. Ltd. appears dormant post-acquisition.

Therapeutic areas: CardiovascularInfectious Diseases
Modalities: Immunoassay DiagnosticsRapid Diagnostics
Industry: Investors

Beyond the preview

Go deeper on 1077801 B.C. Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 1077801 B.C. Ltd..

Explore the full profile